Building Next-Generation Therapeutic Biologics
About Us
Simisco Biosciences is a protein engineering company developing antibody-based therapeutics and novel biologic drug candidates for cancer and chronic, degenerative and infectious diseases.
Innovative Antibody Engineering Technology
Using its extensive portfolio of Fabs and scFvs targeting hundreds of disease-associated proteins, Simisco engineers complex multivalent and multispecific antibody molecules as therapeutic-grade drug candidates designed to modulate target function for therapeutic needs.
Our Team & Global Research Network
Simisco was established by Dr. Sachdev Sidhu, PhD and is now led by an experienced team of scientists and business leaders. With locations in Ontario, Canada; California, USA; and Kerala, India, Simisco’s team brings in a variety of perspectives and talent.
